Text Size
478 studies found for:    Thrombocytopenia: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Thrombocytopenia: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting WEUSKOP5410: Observational Study in ENABLE Clinical Trials
Conditions: Phlebitis;   Hepatitis C;   Unstable Angina;   Deep Vein Thrombosis;   Ischemic Stroke;   Pulmonary Embolism;   Ischaemic Attack, Transient;   Thrombocytopenia;   Thrombophlebitis;   Myocardial Infarction;   Portal Vein Thrombosis
Intervention: Drug: eltrombopag
2 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic;   Thrombocytopenia
Interventions: Drug: Eltrombopag (Promacta);   Drug: Eltrombopag
3 Not yet recruiting A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Condition: Purpura, Thrombocytopaenic, Idiopathic
Interventions: Drug: Belimumab;   Drug: Normal saline placebo
4 Active, not recruiting Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
Condition: Oedema
Interventions: Drug: Eltrombopag;   Drug: Placebo
5 Completed Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Condition: Heparin Induced Thrombocytopenia
Intervention:
6 Unknown † A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
Condition: Heparin-Induced Thrombocytopenia
Intervention:
7 Recruiting A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Condition: Thrombocytopaenia
Interventions: Drug: eltrombopag;   Drug: placebo
8 Unknown † The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)
9 Completed Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: argatroban
10 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711
11 Recruiting A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
Conditions: Myelodysplastic Syndromes (MDS);   Acute Myeloid Leukaemia (AML)
Intervention: Drug: Azacitidine and eltrombopag
12 Completed Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
Conditions: Sarcoma;   Thrombocytopenia;   Thrombocytopaenia;   Thrombopoiesis
Intervention: Drug: eltrombopag
13 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
14 Active, not recruiting Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With ITP
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
15 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
16 Recruiting Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag olamine;   Other: Placebo
17 Recruiting A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Condition: Chemotherapy-Induced Thrombocytopenia
Intervention: Drug: ONO-7746
18 Terminated
Has Results 		Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
Condition: Thrombocytopenia
Intervention:
19 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban
20 Recruiting A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura
Condition: Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Intervention: Biological: Romiplostim
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years